HSBC Holdings’s Caribou Biosciences CRBU Stock Holding History

HSBC Holdings’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61.9K	Hold	34,460	–	–	﹤0.01%	2848
2026 Q1	$65.3K	Hold	34,460	–	–	﹤0.01%	2789
2025 Q4	$55K	Hold	34,460	–	–	﹤0.01%	2858
2025 Q3	$78.2K	Sell	34,460 -80,183	-70%	-$151K	﹤0.01%	2617
2025 Q2	$147K	Buy	114,643 +66,670	+139%	+$65.6K	﹤0.01%	2772
2025 Q1	$43.7K	Sell	47,973 -63	-0.1%	-$82	﹤0.01%	2919
2024 Q4	$74.7K	Buy	48,036 +2,861	+6%	+$5.75K	﹤0.01%	2938
2024 Q3	$88.3K	Sell	45,175 -35,692	-44%	-$73.1K	﹤0.01%	2814
2024 Q2	$129K	Buy	80,867 +66,838	+476%	+$214K	﹤0.01%	2684
2024 Q1	$72.1K	Buy	+14,029	New	+$86.5K	﹤0.01%	2893

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HSBC Holdings's CRBU Position: Q2 2026 in Review

HSBC Holdings held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 34,460 shares worth $61.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2848.

HSBC Holdings first reported a position in CRBU in Q1 2024 and has held it in 10 quarters since. The position peaked at $147K in Q2 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

HSBC Holdings held 34,460 shares of Caribou Biosciences worth $61.9K as of Q2 2026.
HSBC Holdings left its Caribou Biosciences share count unchanged in Q2 2026.
Caribou Biosciences made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2848 holding.
HSBC Holdings first reported a position in Caribou Biosciences in Q1 2024 and has held it in 10 quarters since.
HSBC Holdings's Caribou Biosciences position peaked at $147K in Q2 2025.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.